Tirzepatide has a longer pharmacokinetic profile, so a longer initial assessment window is appropriate
5-12 However, in clinical trials, including SURMOUNT-1 for tirzepatide and STEP 1 for semaglutide, participants were permitted to remain on a given dose for up to 4 additional weeks, as needed, to allow for the dissipation of any GI AEs
Back Toiv, B (30 July 2013) 'Dr
GLP-1 medicationsshort for glucagon-like peptide-1 receptor agonistsare prescription drugs that help regulate appetite, slow digestion, and improve blood sugar control
In people with lower starting weights, small doses could have big impacts, he says
Other GLP-1 tablets, such as Rybelsus, have been available for type 2 diabetes in the UK for a while, but were not licensed for weight loss